{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:25:03Z","timestamp":1781346303402,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10549-019-05467-7","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T19:40:29Z","timestamp":1571254829000},"page":"435-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Quality and quantity of visceral fat tissue are associated with insulin resistance and survival outcomes after chemotherapy in patients with breast cancer"],"prefix":"10.1007","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5302-2292","authenticated-orcid":false,"given":"Toshiaki","family":"Iwase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Sangai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Sawabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"5467_CR1","unstructured":"Society AC (2018) Breast Cancer Facts & Figures\u00a02017-2018"},{"key":"5467_CR2","unstructured":"Cancer Facts & Figures\u00a02018 [Internet] (2018) Available from: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2018\/cancer-facts-and-figures-2018.pdf"},{"key":"5467_CR3","unstructured":"Prevalence of Obesity Among Adults and Youth: United States, 2015\u20132016 [Internet]. 2017. Available from: https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db288.pdf"},{"issue":"1","key":"5467_CR4","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10549-015-3287-5","volume":"150","author":"C Fontanella","year":"2015","unstructured":"Fontanella C, Lederer B, Gade S, Vanoppen M, Blohmer JU, Costa SD et al (2015) Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials. Breast Cancer Res Treat 150(1):127\u2013139","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5467_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.breast.2013.11.008","volume":"23","author":"T Iwase","year":"2014","unstructured":"Iwase T, Nakamura R, Yamamoto N, Yoshi A, Itami M, Miyazaki M (2014) The effect of molecular subtype and body mass index on neo-adjuvant chemotherapy in breast cancer patients. Breast 23(3):264\u2013272","journal-title":"Breast"},{"issue":"25","key":"5467_CR6","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1200\/JCO.2007.14.4527","volume":"26","author":"JK Litton","year":"2008","unstructured":"Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M et al (2008) Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol 26(25):4072\u20134077","journal-title":"J Clin Oncol"},{"issue":"4","key":"5467_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1172\/JCI10842","volume":"106","author":"BB Kahn","year":"2000","unstructured":"Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Investig 106(4):473\u2013481","journal-title":"J Clin Investig"},{"issue":"4","key":"5467_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3390\/jcm3041561","volume":"3","author":"MS Lewitt","year":"2014","unstructured":"Lewitt MS, Dent MS, Hall K (2014) The insulin-like growth factor system in obesity, insulin resistance and type 2 diabetes mellitus. J Clin Med 3(4):1561\u20131574","journal-title":"J Clin Med"},{"issue":"18","key":"5467_CR9","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","volume":"92","author":"H Yu","year":"2000","unstructured":"Yu H, Rohan T (2000) Role of the insulin-like growth factor family in cancer development and progression. JNCI 92(18):1472\u20131489","journal-title":"JNCI"},{"issue":"1","key":"5467_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1158\/1055-9965.EPI-15-0334-T","volume":"25","author":"RS Cecchini","year":"2016","unstructured":"Cecchini RS, Swain SM, Costantino JP, Rastogi P, Jeong JH, Anderson SJ et al (2016) Body mass index at diagnosis and breast cancer survival prognosis in clinical trial populations from NRG Oncology\/NSABP B-30, B-31, B-34, and B-38. Cancer Epidemiol Biomark Prev 25(1):51\u201359","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"4","key":"5467_CR11","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.clbc.2016.02.018","volume":"16","author":"T Erbes","year":"2016","unstructured":"Erbes T, Stickeler E, Rucker G, Buroh S, Asberger J, Dany N et al (2016) BMI and pathologic complete response to neoadjuvant chemotherapy in breast cancer: a Study and Meta-Analysis. Clin Breast Cancer 16(4):e119\u2013e132","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"5467_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10549-016-3918-5","volume":"159","author":"ET Warner","year":"2016","unstructured":"Warner ET, Ballman KV, Strand C, Boughey JC, Buzdar AU, Carey LA et al (2016) Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426). Breast Cancer Res Treat 159(1):109\u2013118","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5467_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mam.2012.10.004","volume":"34","author":"GV Denis","year":"2013","unstructured":"Denis GV, Obin MS (2013) \u2018Metabolically healthy obesity\u2019: origins and implications. Mol Aspects Med 34(1):59\u201370","journal-title":"Mol Aspects Med"},{"issue":"1","key":"5467_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/cam4.571","volume":"5","author":"T Iwase","year":"2016","unstructured":"Iwase T, Sangai T, Nagashima T, Sakakibara M, Sakakibara J, Hayama S et al (2016) Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients. Cancer Med 5(1):41\u201348","journal-title":"Cancer Med"},{"issue":"33","key":"5467_CR15","doi-asserted-by":"publisher","first-page":"34475","DOI":"10.18632\/oncotarget.5922","volume":"6","author":"A Ritter","year":"2015","unstructured":"Ritter A, Friemel A, Fornoff F, Adjan M, Solbach C, Yuan J et al (2015) Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells. Oncotarget 6(33):34475\u201334493","journal-title":"Oncotarget"},{"key":"5467_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1758-5996-3-12","volume":"3","author":"CL Donohoe","year":"2011","unstructured":"Donohoe CL, Doyle SL, Reynolds JV (2011) Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr 3:12","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"5467_CR17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jnutbio.2010.04.015","volume":"22","author":"V Catalan","year":"2011","unstructured":"Catalan V, Gomez-Ambrosi J, Rodriguez A, Ramirez B, Silva C, Rotellar F et al (2011) Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer. J Nutr Biochem 22(7):634\u2013641","journal-title":"J Nutr Biochem"},{"issue":"15","key":"5467_CR18","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.7150\/jca.16884","volume":"7","author":"R Divella","year":"2016","unstructured":"Divella R, De Luca R, Abbate I, Naglieri E, Daniele A (2016) Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer 7(15):2346\u20132359","journal-title":"J Cancer"},{"issue":"10","key":"5467_CR19","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1158\/1055-9965.EPI-09-0372","volume":"18","author":"RC van Kruijsdijk","year":"2009","unstructured":"van Kruijsdijk RC, van der Wall E, Visseren FL (2009) Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomark Prevent 18(10):2569\u20132578","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"7","key":"5467_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jcmg.2012.11.021","volume":"6","author":"KJ Rosenquist","year":"2013","unstructured":"Rosenquist KJ, Pedley A, Massaro JM, Therkelsen KE, Murabito JM, Hoffmann U et al (2013) Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc Imaging 6(7):762\u2013771","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"5467_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/21623945.2015.1106057","volume":"5","author":"JA Cote","year":"2016","unstructured":"Cote JA, Nazare JA, Nadeau M, Leboeuf M, Blackburn L, Despres JP et al (2016) Computed tomography-measured adipose tissue attenuation and area both predict adipocyte size and cardiometabolic risk in women. Adipocyte 5(1):35\u201342","journal-title":"Adipocyte"},{"issue":"1","key":"5467_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/RCT.0b013e3181fc2150","volume":"35","author":"HH Hu","year":"2011","unstructured":"Hu HH, Chung SA, Nayak KS, Jackson HA, Gilsanz V (2011) Differential computed tomographic attenuation of metabolically active and inactive adipose tissues: preliminary findings. J Comput Assist Tomogr 35(1):65\u201371","journal-title":"J Comput Assist Tomogr"},{"issue":"25","key":"5467_CR23","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1200\/JCO.2005.06.232","volume":"23","author":"MC Green","year":"2005","unstructured":"Green MC, Buzdar AU, Smith T, Ibrahim NK, Valero V, Rosales MF et al (2005) Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks. J Clin Oncol 23(25):5983\u20135992","journal-title":"J Clin Oncol"},{"issue":"2","key":"5467_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5858\/arpa.2013-0953-SA","volume":"138","author":"AC Wolff","year":"2014","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH et al (2014) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med 138(2):241\u2013256","journal-title":"Arch Pathol Lab Med"},{"key":"5467_CR25","volume-title":"American Joint Committee on cancer staging manual","author":"SBBD Edge","year":"2009","unstructured":"Edge SBBD, Compton CC, Fritz AG, Greene FL, Trotti A (2009) American Joint Committee on cancer staging manual, 7th edn. Spinger, New York","edition":"7"},{"issue":"14","key":"5467_CR26","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2016.06.067","volume":"68","author":"JJ Lee","year":"2016","unstructured":"Lee JJ, Pedley A, Hoffmann U, Massaro JM, Fox CS (2016) Association of changes in abdominal fat quantity and quality with incident cardiovascular disease risk factors. J Am Coll Cardiol 68(14):1509\u20131521","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 2","key":"5467_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1467-789X.2012.01035.x","volume":"13","author":"F Item","year":"2012","unstructured":"Item F, Konrad D (2012) Visceral fat and metabolic inflammation: the portal theory revisited. Obes Rev 13(Suppl 2):30\u201339","journal-title":"Obes Rev"},{"issue":"2","key":"5467_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/ajcn\/80.2.271","volume":"80","author":"W Shen","year":"2004","unstructured":"Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J et al (2004) Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr 80(2):271\u2013278","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"5467_CR29","first-page":"187","volume":"17","author":"K van der Kooy","year":"1993","unstructured":"van der Kooy K, Seidell JC (1993) Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 17(4):187\u2013196","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"5467_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/oby.2003.3","volume":"11","author":"W Shen","year":"2003","unstructured":"Shen W, Wang Z, Punyanita M, Lei J, Sinav A, Kral JG et al (2003) Adipose tissue quantification by imaging methods: a proposed classification. Obes Res 11(1):5\u201316","journal-title":"Obes Res"},{"issue":"1","key":"5467_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1017\/S002966511100320X","volume":"71","author":"SL Doyle","year":"2012","unstructured":"Doyle SL, Donohoe CL, Lysaght J, Reynolds JV (2012) Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc 71(1):181\u2013189","journal-title":"Proc Nutr Soc"},{"issue":"12","key":"5467_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8(12):915\u2013928","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"5467_CR33","doi-asserted-by":"crossref","first-page":"e002545","DOI":"10.1161\/JAHA.115.002545","volume":"5","author":"JJ Lee","year":"2016","unstructured":"Lee JJ, Pedley A, Hoffmann U, Massaro JM, Keaney JF Jr, Vasan RS et al (2016) Cross-sectional associations of computed tomography (CT)-derived adipose tissue density and adipokines: the Framingham Heart Study. J Am Heart Assoc 5(3):e002545","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"5467_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1148\/radiology.188.1.8511316","volume":"188","author":"K Ohtomo","year":"1993","unstructured":"Ohtomo K, Baron RL, Dodd GD 3rd, Federle MP, Miller WJ, Campbell WL et al (1993) Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology 188(1):31\u201335","journal-title":"Radiology"},{"issue":"11","key":"5467_CR35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ncpendmet0976","volume":"4","author":"JI Odegaard","year":"2008","unstructured":"Odegaard JI, Chawla A (2008) Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat Clin Pract Endocrinol Metab 4(11):619\u2013626","journal-title":"Nat Clin Pract Endocrinol Metab"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05467-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T23:04:11Z","timestamp":1664665451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05467-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5467"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05467-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"8 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}